Literature DB >> 2058267

Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody.

R Hunter1, M Olsen, S Buynitzky.   

Abstract

The adjuvant activity of block copolymers varies with the lengths of the chains of polyoxypropylene (POP) and polyoxyethylene (POE). This project evaluated the adjuvant activity of new copolymers with long polyoxypropylene chains in mice immunized with TNP-hen egg albumin in 2% squalone-in-water emulsions. Two of the new copolymers, L141 and L180.5, not only stimulated higher antibody titres to TNP than older preparations, but also induced a higher percentage of the IgG2 isotypes. The smaller older copolymers, L101 and L121, induced higher absolute levels of IgG3 antibody and relative increases in IgG1. Incorporation of immunomodulators (cell wall skeletons, monophosphoryl lipid A or threonyl muramyl dipeptide) increased mean IgG titres but also increased variability of responsiveness among individuals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058267     DOI: 10.1016/0264-410x(91)90108-i

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 2.  Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress.

Authors:  M Z Khan; J P Opdebeeck; I G Tucker
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

3.  Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.

Authors:  I M Fernández; A Snijders; B J Benaissa-Trouw; M Harmsen; H Snippe; C A Kraaijeveld
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo.

Authors:  C Jagannath; H S Allaudeen; R L Hunter
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 5.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

6.  Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.

Authors:  J H van de Wijgert; A F Verheul; H Snippe; I J Check; R L Hunter
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  Enhancement of antibiotic susceptibility and suppression of Mycobacterium avium complex growth by poloxamer 331.

Authors:  R L Hunter; C Jagannath; A Tinkley; C A Behling; F Nolte
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Construction of chimeric immunogens: Bioactive fragment of human IL-1β or polytuftsin (PT) capable of eliciting immune responses to HIV peptides.

Authors:  K Gokulan; S Khare; D N Rao
Journal:  Indian J Clin Biochem       Date:  1998-07

9.  Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

Authors:  Elena V Batrakova; Shu Li; Anna M Brynskikh; Amit K Sharma; Yili Li; Michael Boska; Nan Gong; R Lee Mosley; Valery Yu Alakhov; Howard E Gendelman; Alexander V Kabanov
Journal:  J Control Release       Date:  2010-01-13       Impact factor: 9.776

10.  Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

Authors:  E A de Velasco; D Merkus; S Anderton; A F Verheul; E F Lizzio; R Van der Zee; W Van Eden; T Hoffman; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.